Improving cancer outcomes and leadership course: an ESO, ECO, SPCC European initiative
01.06.2022 - 09.07.2022
Chairs: Alexandru Eniu, Razvan Popescu and Peter Selby.
The SPCC, ESO and ECO Improving Outcomes and Leadership course is aimed at helping to tackle the difficult challenge of inequalities in cancer outcomes across Europe.
This training programme will provide mid-career cancer healthcare professionals (of all disciplines), industry professionals, patient advocates and those working in regulatory bodies with the expertise required to develop strategic plans, support and collaborate in relevant applied health research, develop implementation approaches and the skillset to support change management within their countries and regions, in order to improve the quality of care and patient outcomes.
The Training Programme will be developed in close collaboration with patients and patient advocates to ensure that we retain a patient-centred approach. The Training Programme will address overarching issues including early diagnosis, specialised multidisciplinary care, patient-centred approaches, integrated care and the systematic use of existing knowledge. It will engender within participants a clear recognition of the importance of Research and Innovation and clinical trials to 21st century patient care
It is intended that the participants of this course will represent many European countries and that they will remain in contact and develop a network for shared approaches and best practice. Participants will be asked to share examples showing initiatives and challenges to improve clinical practice in their countries during the course.
- Build the skills and train individuals to work to improve cancer patient outcomes
- Share examples of best practice across Europe
- Create a network of trained individuals who will continue to work together to improve cancer patient outcomes
- Allow trainees to work together with senior colleagues and European advisors to develop country-specific proposals for improving outcomes
- The European Code of Cancer Practice
- Strategic healthcare improvement skills
- Awareness and implementation of good practice
- Innovation based on sound evidence and the appropriate interpretation of RCT data
- Change management skills
This event is held in partnership with:
|European School of Oncology
|European Cancer Organisation
Improving Cancer Outcomes and Leadership course will be a combination of the following:
- Block 1 - 5 pre-event online learning sessions
- Block 2 - A 3 day in-person event
Location: Warsaw, Poland
Dates: 7-9 July 2022
Sessions for both parts of the programme will be sponsored by each contributing organisation. The online learning sessions must be completed by participants before the in-person event.
ESCO - The ESO College
Being selected to take part in this course is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.The course also enables ESCO members to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the course earns participants 18 ESCO credits.Visit www.ESCO.org for more information on how to join ESCO.
European School of Oncology
Via Turati 29, 20121, Milan (IT)
European School of Oncology
Piazza Indipendenza 1, Bellinzona (CH)
For more information please contact also email@example.com or firstname.lastname@example.org
The course will be held in English and translation will not be provided.
The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.
Mid-career oncology professionals who have finished training and have a stable position. Involved in or starting to be involved in improving outcomes. Preparing to take on initiatives/leadership responsibilities/managerial roles;
- Mid-career managers of hospitals or clinics;
- Mid-career Health Care Professionals with managerial roles;
- Mid-high-level representatives of patient organisations;
- Industry representatives;
- Regulatory bodies.
Priority is given to ESCO Graduates
Fluency in English is required
How to apply
Interested candidates should apply online at
providing the following:
- CV & list of publications if oncology professional or affiliation if patient advocate/industry/regulatory body;
- Motivation letter;
- Completed template for Examples of initiatives and challenges.
Examples of initiatives and challenges template
Please complete the attached template giving an example of practice that has changed outcomes, or a practice that was implemented to change outcomes but didn’t work. Selected participants will have the opportunity to present their example in the format of a slide presentation (max. 10) to the participants and faculty members during the breakout sessions (as mentioned in the programme). Please don’t submit presentations at this stage in the application process.
ATTENDANCE TO THE COURSE IS BY APPLICATION ONLY
Successful applicants are granted:
- free registration, full board and accommodation
All participants will be expected to reside at the course venue and their full participation is compulsory throughout the course. Travel costs must be covered by the participants themselves.
APPLICATION DEADLINE: 14th March 2022
Matti Aapro, Sharing Progress in Cancer Care and Clinique de Genolier, Bellinzona and Genolier, Switzerland
Ajay Aggarwal, London School of Hygiene and Tropical Medicine, Dept of Health Services Research and Policy, London, UK
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Andreas Charalambous, Cyprus University of Technology, Dept. of Oncology Nursing, Limassol, CY
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Stein Kaasa, Oslo University Hospital, Department of Oncology, Oslo, NO
Mark Lawler, Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
Yolande Lievens, K.U. Leuven, Dept.Radiotherapy, Leuven, BE
Kathy Oliver, International Brain Tumour Alliance - IBTA, Patient Advocacy Dept., Tadworth, Surrey, UK
Eduardo Pisani, All.Can International, Patient Advocacy Dept., Brussels, BE
Razvan Popescu, Tumor Center Aarau / Hirslanden Klinik Aarau, Medical Oncology / Hematology / Palliative Care Dpt., Aarau, CH
Pietro Presti, Fondazione Edo & Elvo Tempia, ., Biella, IT
Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Dept. of Soft Tissue/Bone & Melanoma, Warszawa, PL
Florian Scotté, Institute Gustave Roussy, Medical Oncology and supportive care department, Villejuif, FR
Peter Selby, University of Leeds/St. James's University Hospital/European Cancer Concord, Dept. of Cancer Research, Leeds, UK
Richard Sullivan, King's Comprehensive Cancer Centre, Institute of Cancer Policy, London, UK